Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02334319Phase 1Terminated
Ganetespib Window of Opportunity Study in Head and Neck Cancers
Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oral Cavity Squamous Cell Carcinoma+13 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Chandylen Nightingale

Wake Forest University Health Sciences

Related
1 trials

Shared therapeutic areas:

Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Similarity Score23%

Greg Wolf

University of Michigan Rogel Cancer Center

Related
1 trials

Shared therapeutic areas:

Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+8 more
Similarity Score21%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Stage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell Carcinoma+6 more
Similarity Score17%

Shlomo Koyfman

Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Stage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Oral Cavity Squamous Cell Carcinoma+5 more
Similarity Score15%

Mercedes Porosnicu

Wake Forest University Health Sciences

Related
2 trials

Shared therapeutic areas:

Stage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma+5 more
Similarity Score15%

Daniel Ma

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Stage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell Carcinoma+1 more
Similarity Score8%

Eric Chen

University Health Network-Princess Margaret Hospital

Related
1 trials

Shared therapeutic areas:

Stage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell Carcinoma+1 more
Similarity Score8%

Daniel Clayburgh

OHSU Knight Cancer Institute

Related
2 trials

Shared therapeutic areas:

Stage I Oropharyngeal Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell Carcinoma
Similarity Score6%

Eric Winquist

University Health Network Princess Margaret Cancer Center P2C

Related
1 trials

Shared therapeutic areas:

Stage IVA Laryngeal Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell Carcinoma
Similarity Score4%

Jon Chan

Roswell Park Cancer Institute

Related
1 trials

Shared therapeutic areas:

Stage I Oral Cavity Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02334319Phase 1PrincipalInvestigator

Ganetespib Window of Opportunity Study in Head and Neck Cancers

Stage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Oral Cavity Squamous Cell Carcinoma+13 more
Terminated

All 1 trials loaded